NASHVILLE, Tenn., Nov. 19, 2026 — Optura, the enterprise healthcare platform that delivers ROAI™ (Return on AI Investment), today announced it has been named to CB Insights’ 2026 Digital Health 50, the market intelligence firm’s eighth annual ranking of the most promising private digital health startups. Optura is one of four companies recognized in the AI infrastructure and governance category.
CB Insights’ 2026 report shows AI expanding from administrative work into patient care. Twenty-six of this year’s 50 winners focus on tasks such as insurance approvals and patient coordination, and several use AI for clinical work, including monitoring patients and recommending prescription renewals.
“We built Optura for healthcare leaders who need to know what their AI is returning, and this recognition reflects that work,” said Andy Fanning, co-founder and co-CEO of Optura. “AI is now part of how healthcare runs, and that raises the stakes on every dollar behind it. We’ve always believed AI should be held to the results it delivers, like any other investment. Being recognized in AI infrastructure and governance tells us the industry is reaching the same conclusion.”
Optura is how healthcare organizations decide which AI investments to fund and hold them accountable once they’re running. Every investment sits in one place, with its expected return tracked against what it delivers, so leaders can move budget to what’s working. The platform manages over $15 billion in AI initiatives.
CB Insights analysts chose this year’s winners from more than 50,000 digital health startups ranging from pre-seed to Series C. They weighed deal activity, industry partnerships, investor strength, hiring momentum, revenue and CB Insights’ Mosaic and Commercial Maturity scores. By Mosaic Score, the 2026 winners rank among the top 10% of private companies globally for overall health and growth potential.
The full list and CB Insights’ analysis are available in the 2026 Digital Health 50 report.
